The 1,000th patient completed one-year of follow-up in X-Bolt Orthopaedics' World Hip Trauma Evaluation 4 study.
Five things to know:
1. Patients in the study either received the X-BOLT hip fracture fixation device or a gold standard sliding hip screw device. The implant is designed to reduce reoperation rates.
2. X-Bolt Orthopaedics began recruiting patients for the study in June 2016. The company collaborated with 10 centers that were working with the Orthopaedic Trauma Society.
3. Follow-ups to evaluate the patients were conducted at four months and one-year postoperatively.
4. A previous study found zero patients who received the X-BOLT required revision operations while 6 percent of the standard-group patients required reoperations.
5. Results of the current study are expected to be released in June. The company earned FDA clearance in the U.S. for the X-BOLT in the fourth quarter of 2018.